Pura Vida Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,000
Closed -$2.4M 233
2022
Q3
$2.19M Buy
+50,000
New +$2.43M 0.13% 130
2022
Q1
Sell
-152,273
Closed -$8.99M 274
2021
Q4
$8.99M Buy
+152,273
New +$7.54M 0.33% 79
2016
Q3
Sell
-124,029
Closed -$4.14M 95
2016
Q2
$4.14M Sell
124,029
-86,771
-41% -$2.77M 1.76% 25
2016
Q1
$5.93M Buy
210,800
+18,445
+10% +$527K 2.7% 6
2015
Q4
$5.89M Sell
192,355
-13,043
-6% -$410K 2.49% 13
2015
Q3
$6.12M Buy
205,398
+55,203
+37% +$1.77M 3.49% 7
2015
Q2
$5.14M Buy
+150,195
New +$4.9M 2.63% 8

Other funds holding PFE

Pura Vida Investments's PFE Position: Q4 2022 in Review

Pura Vida Investments sold out of Pfizer (PFE) in Q4 2022, closing a stake of 50,000 shares — an estimated $2.4M sold.

Pura Vida Investments first reported a position in PFE in Q2 2015 and held it in 7 quarters. The position peaked at $8.99M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Pura Vida Investments reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 50,000 Pfizer shares in Q4 2022, an estimated $2.4M.
  • Pura Vida Investments first reported a position in Pfizer in Q2 2015 and held it in 7 quarters.
  • Pura Vida Investments's Pfizer position peaked at $8.99M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.